Halobetasol propionate and tazarotene (Duobrii) Last Updated: January 27, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: Halobetasol propionate and tazarotene Indications: Psoriasis, moderate to severe plaque Brand Name: DuobriiManufacturer: Bausch Health, Canada Inc.Project Number: SR0638-000Project Status: ReceivedSubmission Type: New Combination Details
naltrexone hydrochloride and bupropion hydrochloride (Contrave) Last Updated: January 27, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: naltrexone hydrochloride and bupropion hydrochloride Indications: Chronic weight management in adults Brand Name: ContraveManufacturer: Bausch Health, Canada Inc.Project Number: SR0610-000Project Status: ActiveSubmission Type: New Details
eculizumab (Soliris) Last Updated: January 24, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: eculizumab Indications: Neuromyelitis optica spectrum disorder Brand Name: SolirisManufacturer: Alexion Pharma Canada Corp.Project Number: SR0640-000Project Status: PendingSubmission Type: New Indication Details
teduglutide (Revestive) Last Updated: January 23, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: teduglutide Indications: Short Bowel Syndrome (SBS), pediatrics Brand Name: RevestiveManufacturer: Shire Pharmaceuticals Ireland LimitedProject Number: SR0606-000Project Status: CompleteSubmission Type: New Indication Details
glucagon (Baqsimi) Last Updated: January 24, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: glucagon Indications: Severe hypoglycemic reactions Brand Name: BaqsimiManufacturer: Eli Lilly Canada Inc.Project Number: SR0626-000Project Status: ActiveSubmission Type: New Details
caplacizumab (Cablivi) Last Updated: January 24, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: caplacizumab Indications: Acquired thrombotic thrombocytopenic purpura (aTTP) Brand Name: CabliviManufacturer: Sanofi-Genzyme, a division of sanofi-aventis Canada Inc.Project Number: SR0633-000Project Status: ActiveSubmission Type: New Details
budesonide (Jorveza) Last Updated: January 24, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: budesonide Indications: Eosinophilic esophagitis, adults Brand Name: JorvezaManufacturer: AVIR Pharma Inc.Project Number: SR0634-000Project Status: ActiveSubmission Type: New Details
apomorphine hydrochloride (Kynmobi) Last Updated: January 23, 2020 Result type: Reports Product Line: Common Drug Review Generic Name: apomorphine hydrochloride Indications: Parkinson’s Disease Brand Name: KynmobiManufacturer: Sunovion Pharmaceuticals Canada Inc.Project Number: SR0604-000Project Status: WithdrawnSubmission Type: New Details
Entrectinib (TBD) for ROS1-positive Non-Small Cell Lung Cancer Last Updated: January 24, 2020 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10206 Details
Enzalutamide (Xtandi) for Metastatic Castration Sensitive Prostate Cancer - Details Last Updated: January 24, 2020 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10209 Details
